Stephen C. Frederico 🧠👨🏻‍⚕️

Medical Student at @PittTweet || Founder of AdmitMD Consulting || Aspiring Neurosurgeon and Scientist

[Pitt Center for Image-Guided Neurosurgery @PittCIGNS]

Review describes mechanisms, delivery systems, photosensitizers, and available evidence regarding potential of photodynamic therapy as a novel therapeutic approach for glioblastomas. https://t.co/1mAubmKbVy @hadjiMDPhD @Steve_Frederico @SakibulHuq @UPMCPhysicianEd @JNeurooncol

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC commentary: NK cells link immune-checkpoint blockade immunotherapy and response in melanoma brain metastases https://t.co/bw49OY1Ir9 @BashBrainTumors @Steve_Frederico @PittTweet

[Pitt Neurosurgery @PittNeurosurg]

Study addresses the unique physical and immunological barriers that make glioblastoma challenging to treat and explores the potential therapeutic mechanisms that may overcome these barriers. https://t.co/BZp3HARoP9 @Steve_Frederico @hadjiMDPhD @BashBrainTumors @SakibulHuq

[Gary Kohanbash @BashBrainTumors]

Pleased to share our (exciting) new manuscript! Daul labeled tracers will hopefully help surgeons find and remove pediatric tumors. teamwork. @DrMarcusMalek @PittNeurosurg @ChildrensPgh @PittPediatrics @PittSurgery @SPIEtweets

https://t.co/2y5sMn2wGp

[bioRxiv Immunology @biorxiv_immuno]

CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection https://t.co/EjRePk6j8O #biorxiv_immuno

[Pitt Neurosurgery @PittNeurosurg]

Study suggests pediatric brain tumors exhibit distinct potential for specific immunotherapies, guiding investigators in assessment of appropriate immunotherapy classes and targets in pediatric brain tumors. https://t.co/6BZHEDi23K @Steve_Frederico @GKohanbash @ChildrensPgh

[Pitt Neurosurgery @PittNeurosurg]

Article summarizes role of immunotherapy in current armamentarium for childhood low-grade gliomas and discusses prior results as well as future options to improve disease control. https://t.co/UlI5zrbPmP @ChildrensPgh @GKohanbash @Steve_Frederico @UPMCPhysicianEd

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

@sash_dubinsky Congratulations Sasha! Proud of you

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

Congratulations @MRGneuroonc on your retirement and such an outstanding career!

Thank you for your mentorship throughout the years and for the opportunity to be a part of such a special team at @NIHBrainTumor

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

Congratulations Sydney and team! @PittNeurosurg @ChildrensPgh 🧠

[Gary Kohanbash @BashBrainTumors]

Congratulations Sydney Jackson PhD Candidate on being awarded Best Abstract Award at the 7th Theranostics World Congress in Santiago Chili.. next stop South Africa #theranosticsworldcongress #twc2024

[Frontiers - Pediatrics @FrontPediatrics]

New Research: Myeloid cells as potential targets for immunotherapy in pediatric gliomas: Pediatric high-grade glioma (pHGG) including pediatric glioblastoma (pGBM) are highly aggressive pediatric central nervous system (CNS) malignancies.… https://t.co/9ra1CJwQNQ #Pediatrics

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

@NikhilSharma_MS Let’s go!!!!!!!!!

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

Thank you to the incredible team that all contributed so much to this effort!

@SuchetTaori
@NikhilSharma_MS
@sash_dubinsky
@zel_zhang

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

In this review our team at @PittNeurosurg highlight specific mechanisms myeloid cells can use to induce immune suppression in pediatric gliomas, as well as non-CNS tumors.

https://t.co/bB02SoxnEx

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

In this newly released study, our team at @PittNeurosurg developed a molecular imaging agent to visualize TIGIT (an immune suppression marker) in pre-clinical GBMs. Great work team! 🎉

https://t.co/Nx61pXB1Dh

[Sina Neyazi @SinaNeyazi]

Very happy to share our results on the molecular characterization and classification of spinal ependymomas (SP-EPN). SP-EPN with biallelic NF2 loss are molecular distinct and associated with a worse outcome compared to SP-EPN without NF2 mutations.
https://t.co/KqlPJOmcYu

[Pitt Med Magazine @PittMedMag]

Working on treating antibiotic-resistant infections in cystic fibrosis patients and finding a new drug therapy for treatment-resistant tumors, respectively, Pitt Med students Anna Li and @Steve_Frederico have received fellowships for their pursuits.

https://t.co/vtMsXorrKO

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

So blessed to be a part of this amazing team!

[Mariella Filbin @FilbinMariella]

Wonderful lab retreat with the best lab crew ever! So happy we could enjoy this gorgeous summer day in Woods Hole together. I’m floored by all your amazing stories and determination to move the needle for our patients. The (pie in the) sky is the limit! 😍☀️🤩#BrainCancer

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

@riyamdange Enjoy!! I hear great things!

[Stephen C. Frederico 🧠👨🏻‍⚕️ @Steve_Frederico]

@ChristieDib01 Absolutely! I’ll have a lobster roll waiting for you 🦞